Clinical Trials
8 trialsNCT05546476 2026-06-03
PROACC-1
Pfizer
Phase 2 Completed
NCT04803305 2024-01-12
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Phase 1 Completed
NCT04299048 2023-12-14
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Phase 1 Completed
NCT04430842 2023-01-18
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
Phase 1 Completed
NCT02968979 2019-09-24
CacheMire
Chugai Pharma France
Completed
NCT00219817 2013-09-02
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed
NCT00527319 2013-01-30
VT-122
Vicus Therapeutics
Phase 2 Completed
NCT00060502 2011-05-17
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Centocor, Inc.
Phase 2 Completed